HPLC of acetyl-L-carnitine in human plasma by derivatization with p-bromophenacyl bromide

Citation
Km. Park et al., HPLC of acetyl-L-carnitine in human plasma by derivatization with p-bromophenacyl bromide, J LIQ CHR R, 24(4), 2001, pp. 555-563
Citations number
10
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Chemistry & Analysis","Spectroscopy /Instrumentation/Analytical Sciences
Journal title
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
ISSN journal
1082-6076 → ACNP
Volume
24
Issue
4
Year of publication
2001
Pages
555 - 563
Database
ISI
SICI code
1082-6076(2001)24:4<555:HOAIHP>2.0.ZU;2-C
Abstract
A high performance liquid chromatographic method is developed for the deter mination of acetyl-L-carnitine (ALC), an endogenous carnitine derivative, i n human plasma, e-Carnitine, which is the structural analogue of ALC, was u sed as an internal standard. The human plasma samples were treated with nin hydrin solution for the removal of amino acids and then extracted with meth anol. After solid phase extraction on silica columns, samples were derivati zed with p-bromophenacyl bromide in the presence of 18-crown-6. The derivative of ALC was quantified by high-performance liquid chromatogra phy with UV detection at 260 nm. The retention time of ALC and e-carnitine was about 27.5 and 22.3 min, respectively. The limit of quantitation was 0. 22 nmol/mL, based on signal to noise ratio of 3. The accuracy deviation of assay was less than 12.86%, and the intra-day and inter-day coefficients of variation (CV, %) were lower than 5.18 and 5.06%, respectively.